Search Results for "B.com Part II Results 2009 Private"

00:10 EST 20th December 2014 | BioPortfolio

Matching Channels

KIACTA

KIACTA™ (also known as eprodisate) is an orally bioavailable small molecule intended for the treatment of AA amyloidosis, an orphan indication that results from long-standing inflammatory cond...

Lipitor

Lipitor was the best selling drug in 2009, with the 2009 annual sales coming in at over $5m for its company, Pfizer Inc. Lipitor is the brand name for an atorvastatin calcium medication that is pres...

The Asymptomatic Patient With Abnormal Laboratory Test Results

MatBA - Mature B-cell neoplasm array

Mature B-cell neoplasms arise in B-cells that have entered germinal centers within lymph nodes as part of the immune response. They display great heterogeneity at the clinical, pathologic, and genet...

Nexium

Nexium is the 2nd most profitable drug in 2009, according to 2009 annual sales figures, where it generated just over $5m in sales for its company, AstraZeneca Pharmaceuticals.  Nexium is a pr...

Matching News

Private Label Nutraceuticals Honored by Inc. 5000 as One of Today’s Fastest Growing Private Companies in America with Three-Year Sales Growth of 620%

Atlanta, GA (PRWEB) August 27, 2014 Private Label Nutraceuticals, prominent contract manufacturer of custom labeled nutritional dietary supplements and products has been recognized by Inc. magazi...

Does a PTA Need On-site Supervision under Part B?

QUESTION: Can a PTA or COTA see a Part B patient without on-site supervision under a group/private practice provider number? ANSWER: No, the therapist must provide direct supervision under "privat...

Statistically Significant Results from the First Part of the Phase 3 ANNEXA™-A Studies of Investigational Andexanet Alfa

November 17, 2014, Portola Pharmaceuticals (NASDAQ: PTLA), Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced results from the first part of the Phase 3 ANNEXA™-A (...

Intra-Cellular Therapies reports positive results from Phase I/II ITI-007 trial

Intra-Cellular Therapies has released additional results from ITI-007-200, a Phase I/II clinical trial of its lead drug candidate, ITI-007, in healthy geriatric subjects (trial Part 1) and in patients...

Medivation: Biopharmaceutical partnering activity 2009 -2014

Medivation, a top big biotech company headquartered in the USA, is focused on development of therapies to treat serious diseases. This article throws light on the partnering activity of this successfu...

Intra-Cellular reports additional results from Phase I/II trial of ITI-007

US-based Intra-Cellular Therapies has reported additional results from a Phase I/II clinical trial (ITI-007-200) of ITI-007, in healthy geriatric subjects (trial Part 1) and in patients with dementia,...

Portola,Bristol-Myers, Pfizer Announce Results From First Part Of Phase 3 ANNEXA

NEW YORK CITY (dpa-AFX) - Portola Pharmaceuticals (PTLA), Bristol-Myers Squibb Co.(BMY) and Pfizer Inc. (PFE) announced results from the first part of the Phase 3 ANNEXA-A or Andexanet Alfa a Nove...

China urges more private capital in health insurance sector

SHANGHAI, Aug 28 (Reuters) - China will encourage more private investment in health insurance, part of Beijing's push to open up its overburdened healthcare sector, the official Xinhua news agency sai...

Matching PubMed Articles

Teaching Basic Life Support to Students of Public and Private High Schools.

Background: Despite being recommended as a compulsory part of the school curriculum, the teaching of basic life support (BLS) has yet to be implemented in high schools in most countries. Objectives: T...

Applicability of the Appropriate use Criteria for Myocardial Perfusion Scintigraphy.

Background: Appropriateness Criteria for nuclear imaging exams were created by American College of Cardiology (ACC) e American Society of Nuclear Cardiology (ASNC) to allow the rational use of tests. ...

Socioeconomic Disparities in Diagnostic Testing after Positive Aneuploidy Screening.

Objective The objective of this study was to investigate the association between type of health insurance (Medicaid vs. private) and uptake of diagnostic testing for fetal aneuploidy after a positiv...

Reflections on public-private participation in healthcare.

Health care is one of the major issues in social policy, affected by multiple factors, such as the increase in health costs, crisis, and the degree of private participation in the financing of service...

Comparative performance of public and private sector delivery of BCG vaccination: Evidence from Sub-Saharan Africa.

The private sector is an important source of health care in the developing world. However, there is limited evidence on how private providers compare to public providers, particularly for preventive s...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement